Dose escalation model for limited-stage small-cell lung cancer

Govindan, 2006, Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database, J Clin Oncol, 24, 4539, 10.1200/JCO.2005.04.4859 Warde, 1992, Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis, J Clin Oncol, 10, 890, 10.1200/JCO.1992.10.6.890 Pignon, 1992, A meta-analysis of thoracic radiotherapy for small-cell lung cancer, N Engl J Med, 327, 1618, 10.1056/NEJM199212033272302 Choi, 1998, Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer, J Clin Oncol, 16, 3528, 10.1200/JCO.1998.16.11.3528 Lichter, 1995, Small cell lung cancer: the influence of dose and treatment volume on outcome, Seminars Radiat Oncol, 5, 44, 10.1016/S1053-4296(05)80009-8 Turrisi, 1999, Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide, N Engl J Med, 340, 265, 10.1056/NEJM199901283400403 De Ruysscher, 2006, Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer, J Clin Oncol, 24, 1057, 10.1200/JCO.2005.02.9793 Erridge, 2003, Thoracic radiotherapy for limited-stage small cell lung cancer: issues of timing, volumes, dose, and fractionation, Semin Oncol, 30, 26, 10.1053/sonc.2003.50017 Scrimger, 2003, Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements, Am J Clin Oncol, 26, 70, 10.1097/00000421-200302000-00014 Adkison, 2008, Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study, Technol Cancer Res Treat, 7, 441, 10.1177/153303460800700605 Komaki, 2005, Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97–12, Int J Radiat Oncol Biol Phys, 62, 342, 10.1016/j.ijrobp.2004.11.030 Mehta, 2001, A new approach to dose escalation in non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 49, 23, 10.1016/S0360-3016(00)01374-2 Fowler, 2001, Biological factors influencing optimum fractionation in radiation therapy, Acta Oncol, 40, 712, 10.1080/02841860152619124 Jeremic, 1997, Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study, J Clin Oncol, 15, 893, 10.1200/JCO.1997.15.3.893 Skarlos, 2001, Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG), Ann Oncol, 12, 1231, 10.1023/A:1012295131640 Takada, 2002, Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104, J Clin Oncol, 20, 3054, 10.1200/JCO.2002.12.071 Lebesque, 1991, The simultaneous boost technique: the concept of relative normalized total dose, Radiother Oncol: J Eur Soc Ther Radiol Oncol, 45, 10.1016/0167-8140(91)90068-R Guttenberger, 1992, Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations, Radiother Oncol, 25, 280, 10.1016/0167-8140(92)90248-S van Rongen, 1993, Recovery from radiation damage in mouse lung: interpretation in terms of two rates of repair, Radiat Res, 133, 225, 10.2307/3578360 van Rongen, 1995, Repair rate in mouse lung after clinically relevant radiation doses per fraction, Radiat Res, 141, 74, 10.2307/3579092 Fowler, 2002, Repair between dose fractions: a simpler method of analyzing and reporting apparently biexponential repair, Radiat Res, 158, 141, 10.1667/0033-7587(2002)158[0141:RBDFAS]2.0.CO;2 Krarup, 1997, Cellular radiosensitivity of small-cell lung cancer cell lines, Int J Radiat Oncol Biol Phys, 38, 191, 10.1016/S0360-3016(97)00245-9 Duchesne, 1986, The acute in vitro and in vivo radiosensitivity of human lung tumour lines, Radiother Oncol, 7, 353, 10.1016/S0167-8140(86)80066-4 Carmichael, 1989, Radiation sensitivity of human lung cancer cell lines, Eur J Cancer Clin Oncol, 25, 527, 10.1016/0277-5379(89)90266-6 Earle, 2000, An assessment of methods to combine published survival curves, Med Decis Making, 20, 104, 10.1177/0272989X0002000113 Bentzen, 2002, From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome, Clin Oncol (R Coll Radiol), 14, 372, 10.1053/clon.2002.0117 Motulsky, 2004 Peto, 1984, The calculation and interpretation of survival curves, 362